According to the [190+ Pages] research study; the global Next Generation Sequencing (NGS) Market in 2018 was approximately USD 2,450 Million. The market is expected to grow at a CAGR of 19.1% and is anticipated to reach around USD 11,776 Million by 2027. Top market players are ABM Inc., Agilent Technologies Inc., BD, BGI, DNASTAR, Eurofins Genomics, F. Hoffmann-La Roche Ltd., Illumina Inc. and others.
New York, NY, March 02, 2021 (GLOBE NEWSWIRE) -- Facts and Factors have published a new research report titled “Next Generation Sequencing (NGS) Market By Products and Services (Products by Technology and Sequencing Services by Type), By Application (Bioinformatics, Genetic Research, Diagnostics, Agriculture & Animal Research, and Drug Discovery), and By End-User (Research Institutes, Academic Institutes, Pharmaceuticals, Hospitals, and Biotechnology Companies): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018 – 2027”.
“According to the research study, the global Next Generation Sequencing (NGS) Market was estimated at USD 2,450 Million in 2018 and is expected to reach USD 11,776 Million by 2027. The global Next Generation Sequencing (NGS) Market is expected to grow at a compound annual growth rate (CAGR) of 19.1% from 2019 to 2027”.
Next generation sequencing (NGS) is also referred to as throughput sequencing. The term is coined to define myriad numbers of advanced sequencing technologies that sequence the complete or partial genome sequencing. It uses ultra-high throughput, scalability, and promptness to sequence the genome. Next generation sequencing is a method that helps in determining the exact sequence of nucleotides inside a genome molecule. Next generation sequencing assists in rapid sequencing of DNA and RNA and at reasonable costs in comparison to the earlier sequencing methods. This next generation sequencing (NGS) technology screens the sequential totaling of nucleotides to immobilized and spatially arrayed RNA or DNA templates. However, it differs substantially as to how these RNA or DNA templates are produced and how they are interviewed to disclose their sequences.
Request Your Free Sample Report of Next Generation Sequencing (NGS) Market @ https://www.fnfresearch.com/sample/next-generation-sequencing-ngs-market-by-products-and-148
(The free sample of this report is readily available on request).
Our Free Sample Report Includes:
2020 Updated Report Introduction, Overview, and In-depth industry analysis
COVID-19 Pandemic Outbreak Impact Analysis Included
190+ Pages Research Report (Inclusion of Updated Research)
Provide Chapter-wise guidance on Request
2020 Updated Regional Analysis with Graphical Representation of Size, Share & Trends
Includes Updated List of table & figures
Updated Report Includes Top Market Players with their Business Strategy, Sales Volume, and Revenue Analysis
Facts and Factors research methodology
(Note: The sample of this report is updated with COVID-19 impact analysis before delivery)
Key Questions Answered in this Report
1) What was the impact of COVID-19 on the Next Generation Sequencing (NGS) Market?
2) What is the market size, share of the Next Generation Sequencing (NGS) Market?
3) Who are the top market players in Next Generation Sequencing (NGS) Market?
4) What will be the future market of the Next Generation Sequencing (NGS) Market?
Market Size & Forecast by Revenue | 2020−2026
Market Dynamics – Leading trends, growth drivers, restraints, and investment opportunities
Market Segmentation – A detailed analysis by product, by types, end-user, applications, segments, and geography
Competitive Landscape – Top key vendors and other prominent vendors
Inquire more about this report before purchase @ https://www.fnfresearch.com/inquiry/next-generation-sequencing-ngs-market-by-products-and-148
(You may enquire a report quote OR available discount offers to our sales team before purchase.)
Impact Analysis of COVID-19 Pandemic on Businesses: Know Short Term and Long Term Impact
Most of the businesses are facing a growing litany of business-critical concerns related to the coronavirus outbreak, including supply chain disruptions, a risk of a recession, and a potential drop in consumer spending. All these scenarios will play out differently across various regions and industries, making accurate and timely market research more essential than ever.
We at Facts and Factors (http://www.fnfresearch.com) understand how difficult it is for you to plan, strategize, or make business decisions, and as such, we have your back to support you in these uncertain times with our research insights. Our team of consultants, analysts, and experts has developed an analytical model tool for markets that helps us to assess the impact of the virus more effectively on the industrial markets. We are further implementing these insights into our reports for a better understanding of our clients.
Request COVID-19 Impact Analysis on Businesses: https://www.fnfresearch.com/sample/next-generation-sequencing-ngs-market-by-products-and-148
Rise in the clinical applications of NGS to steer the market trends
Funding of NGS technologies by the National Human Genome Research Institute was made to speed up the utilization of genome sequencing data in the clinical practice of medicine. The plethora of applications of NGS for diagnosing ailments like Cancer, psychiatry, cardiology, hematological disorders, hearing impairment, dysmorphology, cardiology, vision & hearing impairment, and pharmacogenomics will steer the business growth.
Furthermore, the usage of cloud technology to store a huge volume of genome data is projected to steer the growth of the next generation sequencing (NGS) industry over the forecast timeline. Nonetheless, the less availability of experts will hinder the expansion of the market during the period from 2019 to 2027. Moreover, short average read lengths are anticipated to put brakes on the market during the forecast timeline.
Industry Major Market Players
The key players included in this market are ABM Inc.,
Agilent Technologies Inc.,
F. Hoffmann-La Roche Ltd.,
Oxford Nanopore Technologies,
Pacific Biosciences of California Inc. QIAGEN,
SciGenom Labs Pvt. Ltd.,
Thermo Fischer Scientific.
To know an additional revised 2020 list of market players, request a sample report: https://www.fnfresearch.com/sample/next-generation-sequencing-ngs-market-by-products-and-148
Sequencing services by type to dominate the product & services segment by 2027
The growth of the segment is attributed to breakthroughs witnessed in sequencing technologies, a rise in the number of sequencing methods, and the introduction of easy-to-use consumables.
Bioinformatics segment to dominate the application landscape over the forecast period
The advancements in the bioinformatics domain are expected to enhance the acceptance of NGS tools in diagnosing a rare form of diseases and detecting therapeutic targets. NGS tools are also used for prenatal testing and this will further steer the segment growth over the forecast period.
The report provides company market share analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product & service launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the market on a global and regional basis.
Directly Purchase a copy of the report with TOC @ https://www.fnfresearch.com/buynow/su/next-generation-sequencing-ngs-market-by-products-and-148
The study provides a decisive view of the next generation sequencing (NGS) market by segmenting the market based on the products and services, application, end-user, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2027. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
The massive utilization of cloud technology for storing a huge volume of genome data is likely to enhance the expansion of the next generation sequencing (NGS) industry during the period from 2019 to 2027. Large-scale investments in NGS technologies by the National Human Genome Research Institute were made to widen the utility of genome sequencing data in the clinical practice of medicine. The plethora of applications of NGS for diagnosing ailments like Cancer, psychiatry, cardiology, hematological disorders, hearing impairment, dysmorphology, cardiology, vision & hearing impairment, and pharmacogenomics will amplify the business growth. Nonetheless, the less availability of experts will impede the expansion of the market during the period from 2019 to 2027. In addition to this, short average read lengths are anticipated to put brakes on the market during the forecast timeline.
Request Customized Copy of Report @ https://www.fnfresearch.com/customization/next-generation-sequencing-ngs-market-by-products-and-148
(We customize your report according to your research need. Ask our sales team for report customization.)
North America to contribute majorly towards the regional market revenue share by 2027
The bulging population along with an increase in the utilization of personalized medicine are a few of the factors that are likely to steer the expansion of the next generation sequencing (NGS) industry during the forecast timeline. The large numbers of giant firms in the business are based in North America and they are making every effort to create innovative products for reducing genome sequencing costs. This, in turn, is anticipated to push the expansion of the regional market over the forecast timeline.
Browse the full “Next Generation Sequencing (NGS) Market By Products and Services (Products by Technology and Sequencing Services by Type), By Application (Bioinformatics, Genetic Research, Diagnostics, Agriculture & Animal Research, and Drug Discovery), and By End-User (Research Institutes, Academic Institutes, Pharmaceuticals, Hospitals, and Biotechnology Companies): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018 – 2027” report at https://www.fnfresearch.com/next-generation-sequencing-ngs-market-by-products-and-148
This report segments the next generation sequencing (NGS) market as follows:
Global Next Generation Sequencing (NGS) Market: By Products and Services Segment Analysis
Products by Technology
Sequencing by Synthesis
Sequencing by Ligation
Ion Semiconductor Sequencing
Sequencing Services by Type
Whole Genome Sequencing
De Novo Sequencing
Total RNA and mRNA Sequencing
Targeted RNA Sequencing
Small RNA and Noncoding RNA Sequencing
Global Next Generation Sequencing (NGS) Market: By Application Segment Analysis
Agriculture and Animal Research
Global Next Generation Sequencing (NGS) Market: By End-User Segment Analysis
Key Features of Next Generation Sequencing (NGS) Market Report:
Next Generation Sequencing (NGS) Market structure: Overview, industry life cycle analysis, supply chain analysis
Next Generation Sequencing (NGS) Market: Growth drivers and constraints, Porter’s five forces analysis, SWOT analysis
Next Generation Sequencing (NGS) Market size, trend, and forecast analysis
Next Generation Sequencing (NGS) Market segments’ trend and forecast
Next Generation Sequencing (NGS) Market’s competitive landscapes: Market share, Product portfolio, New product launches, etc.
Next Generation Sequencing (NGS) Market attractiveness and associated growth opportunities
Emerging Trends in the Next Generation Sequencing (NGS) Market.
Strategic growth opportunities for the existing and new players
Key success factors
Bone Void Fillers Market: https://www.fnfresearch.com/bone-void-fillers-market-by-type-calcium-sulphate
Healthcare Data Interoperability Market: https://www.fnfresearch.com/global-healthcare-data-interoperability-market-by-level-foundational
Central Venous Catheters Market: https://www.fnfresearch.com/central-venous-catheters-market-by-design-single-lumen-301
Pharmaceutical Market: https://www.fnfresearch.com/pharmaceutical-market-by-api-type-synthetic-api-and-294
Biologics Outsourcing Market: https://www.fnfresearch.com/biologics-outsourcing-market-by-product-antibody-vaccines-recombinant-206
About Facts & Factors (FnF Research):
Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds.
Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.
Follow Us LinkedIn: https://www.linkedin.com/company/fnfresearch
Follow Us Twitter: https://twitter.com/fnfresearch
Facts & Factors